Pharmafile Logo

Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural member of ISPOR—The Professional Society for Health Economics and Outcomes Research’s Corporate Partnership Program. This strategic alliance with ISPOR reinforces Genesis Research Group’s commitment to advancing HEOR to inform healthcare decision-making and improve patient access to life-changing therapies.

ISPOR partner seal

As a member of ISPOR’s Corporate Partnership Program, Genesis Research Group will collaborate with ISPOR and the global HEOR community to support initiatives that advance and strengthen HEOR, in alignment with ISPOR’s Strategic Plan 2030. This includes cutting edge research, education and training, and enhancing health outcomes research through evidence-based practices throughout the wider healthcare industry.

“We are very excited to launch the new Corporate Partner Program, welcome Genesis Research Group, and invite them and other organizations to contribute to ISPOR’s vision of a world where healthcare is accessible, effective, efficient, and affordable for all,” commented Rob Abbott, CEO of ISPOR. “Organizations who become ISPOR Corporate Partners will take an active role in the Society’s mission to improve healthcare decisions and achieving this vision, while elevating their presence with key stakeholders.”

“The importance of leveraging HEOR to inform healthcare decision-making has never been greater. By supporting ISPOR and becoming an inaugural member of its Corporate Partnership Program, we are reaffirming our dedication to leveraging real-world evidence, market access, and HEOR transparently and ethically to ensure that healthcare decisions are guided by high-quality evidence,” said David W. Miller, CEO of Genesis Research Group. “We are delighted to join other industry leaders in taking an active role in shaping the future of HEOR.”

MEET GENESIS RESEARCH GROUP AT ISPOR 2025 IN MONTREAL!

Contact solutions@genesisrg.com.

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

World EPA Congress 2024: ‘Shining the light on vaccine market access’ by Genesis Research Group

A presentation with Katrin Nather, PhD, Associate Director, and Tijana Ignjatovic, Executive Director, Genesis Research Group. Contact solutions@genesisrg.com or visit www.genesisrg.com. With more and more innovative vaccines and immunization strategies...

Fit-for-purpose matchmaking webinar: a data selection and RWE approach for both regulatory and HTA audiences

This webinar reviews considerations for the design and data selection for RWE studies, including external control arm studies, to meet regulatory and HTA needs. Regulators and agencies responsible for market...

Genesis Research Group RWD / HTA / regulatory / ECA webinar on 15 Feb: reserve your place!

On 15 February 2024, Carole Longson and Allie Sosinsky of Genesis Research Group, a leading global provider of tech-enabled real-world evidence, market access, and HEOR solutions, will present a webinar...

Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!

Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...

Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer

International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining...